Stay updated on Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page
- Check3 days agoChange DetectedLocations sections have been consolidated under a single Locations heading listing study sites across Arizona, California, District of Columbia, Florida, Indiana, Maryland, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Utah, and Virginia. Revision updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedThe additions note that PubMed publications are automatically filled and may not be about the study, and reference revision v3.3.2; the deletions correspond to older wording about PubMed publications and revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedNotice about government funding lapse was removed from the page, eliminating the banner that warned information may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedThe Study Details page remains unchanged in its core content and data; only minor visual/layout adjustments were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange Detected- Added a government operating status notice and NIH Clinical Center status info, plus a new version tag (v3.2.0). - Removed the old version tag (v3.1.0).SummaryDifference2%

- Check88 days agoChange DetectedAdded a new version label (v3.1.0) and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older version label (v3.0.2); overall, content scope around drug-safety topics appears to be reduced or reorganized.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.